Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Kineta

Request full access

Aims at developing edge therapeutics in autoimmune disease, viral disease, and chronic pain areas

Seattle, United StatesFounded 2008Biotech & Life Sciences

About Kineta

Kineta Inc. is a biopharmaceutical company specializing in the development of first-in-class novel immunotherapies aimed at transforming patient lives. The company focuses on advancing treatments from discovery to proof of concept, particularly in the fields of immuno-oncology and neuroscience. Kineta serves patients suffering from cancer and chronic pain, addressing a significant gap in the biopharmaceutical industry by reprogramming the immune system to target and kill cancer cells and developing non-opioid treatments for chronic pain. Kineta operates in the highly competitive biopharmaceutical market, targeting healthcare providers, research institutions, and pharmaceutical companies as its primary clients. The business model revolves around early-stage drug development, securing funding through investment rounds, and forming strategic partnerships for clinical trials and commercialization. Revenue is generated through licensing agreements, milestone payments, and royalties from successful drug candidates.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2022

Kineta in the Seattle ecosystem

Live from Dealroom

The Kineta office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Wellcome Trust

Series A3 investors entered at this stage

  • Keiretsu Capital
  • Keiretsu Forum
  • SCHLAEPFER FAMILY FOUNDATION

Series B and later2 investors entered at this stage

  • Puget Sound Venture Club
  • Cheongbo Industrial
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Kineta on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.